Metabolic syndrome as a predictor of cardiovascular risk in children and adolescents.
Pediatric Hypertension Program, Children's Hospital at Montefiore, and the Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA. joseph.flynn@seattlechildrens.org
Joseph T
JT
Flynn
D052242:Adiponectin / Q000097:blood*; D000293:Adolescent; D001794:Blood Pressure / Q000502:physiology; D002648:Child; D004452:Echocardiography; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D007333:Insulin Resistance / Q000502:physiology*; D024821:Metabolic Syndrome / Q000097:blood* / Q000150:complications / Q000453:epidemiology; D011379:Prognosis; D012307:Risk Factors; D012720:Severity of Illness Index
D052242:Adiponectin